The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A randomised double-blind placebo-controlled trial. (2018)
Attributed to:
Alpha-1-antitrypsin (AT) deficiency and the serpinopathies: pathobiology and new therapeutic strategies
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0194197
PubMed Identifier: 29566026
Publication URI: http://europepmc.org/abstract/MED/29566026
Type: Journal Article/Review
Volume: 13
Parent Publication: PloS one
Issue: 3
ISSN: 1932-6203